Alexander Mark Schobel

Insider Reports History

Entity
Individual
Location
30 Technology Drive, Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexander Mark Schobel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Common Stock 984K $4.8M $4.88 Mar 15, 2024 Direct
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Performance Stock Units 50K Aug 9, 2023 Direct
Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Non-Qualified Stock Option (right to buy) 41.3K Mar 7, 2024 Direct

Insider Reports Filed by Alexander Mark Schobel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Mar 15, 2024 1 -$300K 4 Mar 19, 2024 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Mar 9, 2024 1 -$47.1K 4/A Oct 2, 2024 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Mar 8, 2024 2 -$158K 4 Mar 12, 2024 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. May 5, 2023 1 $0 4 May 5, 2023 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 9, 2023 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Nov 4, 2022 1 $0 4 Nov 8, 2022 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Jun 8, 2022 2 $50K 4 Jun 10, 2022 Chief Innovation/Tech Officer
AQST Aquestive Therapeutics, Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Chief Innovation/Tech Officer